fbpx
Biomed Israel 2023: The 21th National Life Science & Technology Week • May 16-18, 2023 | David InterContinental • Tel Aviv, Israel

Day 3

THURSDAY, MAY 12

HALL A
09:30-14:00TRANSFORMATIVE PRECISION CANCER DIAGNOSTICS AND THERAPIES
11:00 - 11:30Coffee Break
Chairperson: Ofer Sharon, MD, CEO, OncoHost
09:30 - 09:35Opening Remarks: Ofer Sharon, MD, CEO, OncoHost, "Precision medicine challenges and opportunities"
09:35 - 09:45Prof. Dror Harats, MD, CEO, VBL Therapeutics, "New Treatment strategies for Solid Tumors: major Leaps, but still work to be done"
09:45 - 10:00Prof. Dror Harats, MD, CEO, VBL Therapeutics
10:00 - 10:15
Roni Mamluk, PhD, Founder and CEO, Ayala Pharma
10:15 - 10:30Isaac Israel, CEO, Purple Biotech
10:30 - 10:45Ilana Mandel, PhD, VP, R&D, Biond Biologics
10:45 - 11:00Eran Ophir, PhD, VP Research and Drug Discovery, Compugen
11:30 - 12:00Reddy Prasanth, MD, SVP, Global Enterprise Oncology Head, Covance/Labcorp Drug Development
12:00 - 12:15Ronen Eavri, PhD, Co-founder and CEO, Barcode Nanotech Next Generation Therapeutics
12:15 - 12:30Ofer Sharon, MD, CEO, OncoHost
12:30 - 12:45Avi Veidman, Co-founder and CEO, Nucleai
12:45 - 13:00Vered Bar, PhD, VP, R&D, Curesponse
13:00 - 13:15Inbal Zafir-Lavie, PhD, CEO and Co-founder, Gina Life
13:15 - 13:30Roi Feingersch, PhD, CEO and Founder, FORESEE GENOMICS
13:30 - 13:45Assaf Halevy, Founder and CEO, 2bPrecise, Genomics and Precision Medicine
14:00 - 15:00Lunch Break
HALL B
09:30-14:00DIGITAL RECONSTRUCTION OF HEALTHCARE
11:00 - 11:30Coffee Break
Chairperson: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
09:30 - 09:35Opening Remarks: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
09:35 - 09:55Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups, Amazon Web Services (AWS), "How Big Tech and High Performance Computing will Impact Healthcare and Life Sciences"
09:55 - 10:15Elliot Menschik, MD, PhD, CDO, Resilience, "Software-defined biomanufacturing of therapeutics"
10:15 - 10:30Avinatan Hassidim, Head of Google Israel research group, Google, "Reimagining the medical record"
10:30 - 10:45Prof. Sam Shah, PhD, Chief Medical Strategy Officer, Numan, "Digital first: building a full stack health provider inside and outside the NHS"
10:45 - 11:00Dedi Gilad, CEO and Co-founder, TytoCare, "The state of virtual care industry in the post-COVID era," Fireside chat with: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
11:30 - 11:45Amnon Bar Lev, Co-founder and CEO, Alike.Health
11:45 - 12:00Kira Radinsky, PhD, Founder, CEO and CTO, Diagnostic Robotics
12:00 - 12:15Anat Naschitz, Founder and CEO, 9xchange,; Co-founder, OrbiMed Israel, "9xchange, molecule marketplace"
12:15 - 12:30Amir Trabelsi, Co-founder and CEO, Genoox
12:30 - 12:45Orr Inbar, Co-founder and CEO, QuantHealth
12:45 - 13:00Israel (Srulik) Dvorsky, Co-founder and CEO, TailorMed
13:00 - 13:15Itai Gueta, MD, Institue of Clinical Pharmacology, Sheba Tel Ha Shomer Medical Center, "MDCIone - customer perspective"
13:15 - 13:30Eliran Malki, Co-founder and CEO, Belong.Life
13:30 - 13:45Chris Guiffre, CFO and COO, Pear Therapeutics "ZOOM"
14:00 - 15:00Lunch Break
HALL C
09:30 - 14:00INFECTIOUS DISEASES - BREAKING BARRIERS IN VACCINE DEVELOPMENT, THERAPY AND DIAGNOSIS MODALITIES
11:00 - 11:30Coffee Break
Chairperson: Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital
09:35 - 09:55Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital, "Covid19, where are we going?"
10:00 - 10:20BARRY GREENE, CEO, Sage Therapeutics, USA, "COVID exacerbating mental health issues,"
10:20 - 10:40Prof. Jacob Strahilevitz, MD, Head of the department of Infectious Diseases and Clinical Microbiology, Hadassah Medical Center, "Antimicrobial stewardship: A societal need to combat resistance"
10:40 - 11:00Prof. Ronen Ben Ami, MD, Head of the Infectious Diseases Unit, Tel Aviv Medical Center, "Emerging Fungal Threats in 2022"
11:30 - 11:45Nadav Ben-Dov, PhD, CEO and Co-founder, phenofAST
11:45 - 12:00Eynat Finkelshtein, PhD, CSO, Code Pharma
12:00 - 12:15Moshik Cohen-Kutner, PhD, CEO, Omnix Medical
12:15 - 12:30Jonathan Solomon, CEO and Board Member, Biomx
12:30 - 12:45Nadav Kidron, CEO and Chairman of the Board, Oravax Medical
12:45 - 13:00Einat Galamidi Cohen, MD, VP Medical, Enlivex Therapeutics
13:00 - 13:15Ofer Chen, MD, VP Clinical Development, Clew Medical
13:15 - 13:30Yotam Levin, MD, CEO, NanoPass
13:30 - 13:45Eddie Sadan, Co-founder, Terrapeutics
13:45 - 14:00Tamar Ben-Yedida, PhD, CSO, BiondVax Pharmaceuticals
14:00 - 15:00Lunch Break
PLENARY SESSION
15:15 - 15:45Alban de la Sabliere, SVP, Head of Sanofi Partnering Sanofi, France, "Sanofi: Implementing a Play to a Win Strategy"
15:45 - 16:15Ehud Rivlin, PhD, Israel Site Lead Verily, Israel
16:15 - 16:45Tal Zaks, MD, PhD, Venture Partner, Orbimed, USA, "ZOOM"